Acne therapy with tretinoin in combination with antibiotics. 1975

A M Kligman, and O H Mills, and K J McGinley, and J J Leyden

UI MeSH Term Description Entries
D010545 Peroxides A group of compounds that contain a bivalent O-O group, i.e., the oxygen atoms are univalent. They can either be inorganic or organic in nature. Such compounds release atomic (nascent) oxygen readily. Thus they are strong oxidizing agents and fire hazards when in contact with combustible materials, especially under high-temperature conditions. The chief industrial uses of peroxides are as oxidizing agents, bleaching agents, and initiators of polymerization. (From Hawley's Condensed Chemical Dictionary, 11th ed) Peroxide
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000152 Acne Vulgaris A chronic disorder of the pilosebaceous apparatus associated with an increase in sebum secretion. It is characterized by open comedones (blackheads), closed comedones (whiteheads), and pustular nodules. The cause is unknown, but heredity and age are predisposing factors. Acne
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations
D001585 Benzoyl Peroxide A peroxide derivative that has been used topically for BURNS and as a dermatologic agent in the treatment of ACNE and POISON IVY DERMATITIS. It is used also as a bleach in the food industry. Benzoyl Superoxide,Dibenzoyl Peroxide,Diphenylglyoxal Superoxide,PanOxyl,Peroxide, Benzoyl,Peroxide, Dibenzoyl,Superoxide, Benzoyl,Superoxide, Diphenylglyoxal
D013754 Tetracyclines Closely congeneric derivatives of the polycyclic naphthacenecarboxamide. (Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1117)

Related Publications

A M Kligman, and O H Mills, and K J McGinley, and J J Leyden
August 1998, Journal of the American Academy of Dermatology,
A M Kligman, and O H Mills, and K J McGinley, and J J Leyden
October 2013, The Journal of dermatological treatment,
A M Kligman, and O H Mills, and K J McGinley, and J J Leyden
July 2001, AAPS PharmSciTech,
A M Kligman, and O H Mills, and K J McGinley, and J J Leyden
January 1998, Clinical therapeutics,
A M Kligman, and O H Mills, and K J McGinley, and J J Leyden
January 1983, International journal of dermatology,
A M Kligman, and O H Mills, and K J McGinley, and J J Leyden
January 1975, Modern problems in paediatrics,
A M Kligman, and O H Mills, and K J McGinley, and J J Leyden
August 1974, Arzneimittel-Forschung,
A M Kligman, and O H Mills, and K J McGinley, and J J Leyden
January 1973, The Medical letter on drugs and therapeutics,
A M Kligman, and O H Mills, and K J McGinley, and J J Leyden
July 1973, Drug and therapeutics bulletin,
Copied contents to your clipboard!